Found 7 results
Author Title [ Type(Asc)] Year
Filters: First Letter Of Title is P and Author is Van Veldhuisen, P  [Clear All Filters]
Journal Article
E. Woodle, Van Veldhuisen, P., and , A Prospective, Randomized, Multicenter, Double-Blind Study of Early Corticosteroid Cessation Versus Long-Term Maintenance of Corticosteroid Therapy with Tacrolimus and Mycophenolate Mofetil in Primary Renal Transplant Recipients: One Year Report, Transplant Proc, vol. 37, pp. 804-808, 2005.
P. Martin, Crippin, J., Goldstein, R. M., Artinian, L., Van Veldhuisen, P., Klintmalm, G. D., and Busuttil, R. W., Primary immunosuppressive agent does not affect Hepatitis C recurrence rates following liver transplantation, 2000.
M. Frogel, Nerwen, C., Boron, M., Cohen, A., Van Veldhuisen, P., Harrington, M., and Group, P. Outcomes R., Prevention of Hospitalization Due to Respiratory Syncytial Virus: Results from the Palivizumab Outcomes Registry, J Perinatol, vol. 28, pp. 511-517, 2008.
N. Oden, Van Veldhuisen, P., Wakim, P., Trivedi, M., Somoza, E., and Lewis, D., Power of Automated Algorithms for Combining Time-Line Follow-Back and Urine Drug Screening Test Results in Stimulant-Abuse Clinical Trials, Am J Drug Alcohol Abuse, vol. 37, pp. 350-357, 2011.
S. Cohen, Boron, M., Cohen, A., Van Veldhuisen, P., and Group, thePalivizuma, Patterns of RSV Disease Prophylaxis in Infants with Congenital Heart Disease (CHD): Preliminary Results From the 2002-2003 Palivizumab Outcomes Registry, J Perinatology, vol. 23, p. 594, 2003.
B. Tai, Hu, L., Ghitza, U. E., Sparenborg, S., Van Veldhuisen, P., and Lindblad, R., Patient Registries for Substance Use Disorders, Subst Abuse Rehabil, vol. 5, pp. 81-86, 2014.
M. Hudak, Boron, M., Cohen, A., Van Veldhuisen, P., and Group, thePalivizuma, Palivizumab prophylaxis of RSV disease: demographic and risk factors results from the 2002-2003 Outcomes Registry, 2003.